June 27, 2025 07:00 AM EDT
Peer Review

Bill Meury brings new per­spec­tive to In­cyte as Hop­penot re­tires; Ex-Mor­phoSys CEO leads re­vi­tal­ized Vor Bio

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Kyle LaHucik

Biotech Correspondent

→ Hervé Hop­penot is hand­ing the CEO post at In­cyte to Bill Meury af­ter 11 years lead­ing the Delaware drug­mak­er.

End­points News caught up with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

A din­ner in Paris re­vived talks for Sanofi's $9.5B deal for Blue­print

FDA head Makary’s short-lived CRL ask on KalVista’s drug rais­es more con­cerns of po­lit­i­cal in­ter­ven­tion

Al­pha­bet’s Cal­i­co inks $25M li­cens­ing deal for Mab­well’s IL-11 pro­grams

In­novent brings a new mech­a­nism to obe­si­ty mar­ket with Chi­na ap­proval

Gilead stops RSV an­tivi­ral tri­als af­ter low in­ci­dence rates dur­ing re­cent sea­son

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times